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ABSTRACT 
Nuclear-encoded transcriptional regulatory proteins called transcription factors can potentially influence mitochondrial gene 
expression directly or indirectly. Mitochondria contain their own genome, which encodes 13 of the ∼100 proteins that constitute 
the enzyme complexes of the respiratory chain. Mitochondria are the fuel stations of all eukaryotic cells and functions as central 
component of mammalian cellular survival through production of ATP and re-oxidized NAD. Nuclear respiratory factor-1 (NRF-
1) coordinates the expression of nuclear and mitochondrial genes for mitochondrial biogenesis. It increases mitochondrial 
respiratory capacity and induces expression of a subset of genes governing mitochondrial activity. It has a major function in 
cellular adaptation to energy demands by translating physiological signals into an enhanced capacity for energy production. 
Oxidative stress has been implicated in the pathogenesis of many diseases such as diabetes, cardiovascular disease, cancer and 
neurodegenerative diseases. NRF proteins are also essential in the upregulation of antioxidant and xenobiotic-metabolizing 
enzymes during oxidative stress. NRF-1 plays a role in mediating activation of oxidative stress response genes through 
antioxidant response element and hence, confirms its potential roles in chronic diseases. This review has clearly revealed the 
versatility of NRF- 1 as a therapeutic target and showed that plants could exhibit their fight against diseases through activation 
of NRF-1. 
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INTRODUCTION 
 
NRF-1, a member of the cap'n'collar (CNC) family is an 
important transcription factor for functions in various types of 
cells (Hirotsu et al., 2012; Kim et al., 2016) and is 
ubiquitously expressed in a wide range of tissues (Biswas and 
Chan 2010; Wang et al., 2019) . Other transcription factors in 
the CNC family of basic-leucine zippe (bZIP) transcription 
factors include NFE-2, NRF-2 and NRF-3 and they are 
involved in the regulation of genes with a broad range of 
functions in response to both physiological and exogenous 
signals (Williams et al., 2013; Tonelli et al., 2018). NRF-1 is 
targeted to the endoplasmic reticulum (ER) under 
physiological conditions, which means that it translocates into 
the nucleus in response to an activating signal (Tsuchiya et al., 
2011; Chowdhury et al., 2017). Firstly, NRF-1 was discovered 
to be an activator of the cytochrome c gene and afterwards, 
was found to play a broader function in nuclear-mitochondrial 
interactions (Virbasius et al., 2012; Niu et al., 2019). It is a 
transcriptional activator of nuclear genes that encode a range 
of mitochondrial proteins (Barr et al., 2003; Cardamone et al., 
2018).  
 
Mitochondria play a key role in the synthesis of adenosine 
triphosphate (ATP) by oxidative phosphorylation in almost all 
eukaryotic cells (Satoh et al., 2013; Hahn and Zuryn, 2019).  
Mitochondria biogenesis abnormalities are linked with 
mitochondrial function and mitochondrial number and size 
(Ren et al., 2010; Santos and Kowluru, 2010; Srivastava, 
2017). Mitochondrial dysfunction can be damaging to cell 
viability causing tissue malfunctioning and severe 
pathological disorders due to its role as key player in cellular 
homeostasis (Wenz, 2009, Huang et al., 2019). NRF-1 binds 
to and activates the promoters of many genes of the 
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mitochondrial electron transport system which include 
cytochrome c, NADH dehydrogenase subunit 8, some 
cytochrome oxidase subunits, some ATP synthase subunits, 
mitochondrial transcription factor A (Tfam) (Scarpulla, 2002; 
Cho et al., 2005; Esteras et al., 2016). Tfam is a protein  that 
is encoded by the Tfam gene and controls the transcription, 
replication, damage sensing, and repair of mitochondria DNA 
(Alvarez et al., 2013; Kang et al., 2018). It encodes protein of 
246 amino acids (25 kDa) with a mitochondrial targeting 
presequence of 42 amino acids (Fisher and Clayton, 1985; 
Choi et al., 2004; Kukat et al., 2015). Peroxisome 
proliferator–activated receptor-γ coactivator-1 (PGC-1) 
stimulates the expression of NRF-1 and coactivates the 
transcription function of NRF-1 on the promoter of Tfam (Wu 
et al., 1999; Choi et al., 2014; Cheng et al., 2018).  
 
NRF-1 induces the expression of Tfam, which, along with other 
nuclear-encoded mitochondrial proteins (NEMPS), is taken 
into mitochondria by the protein import machinery (Hood et al., 
2006; Suliman and Piantadosi, 2015). NRF-1 and NRF-2 are 
essential in the regulation of the expression of many antioxidant 
genes which include peroxiredoxin-1 (Prx-1), thioredoxin-1 
(Txn-1), glutamate cysteine ligase catalytic subunit (GCLC), an 
enzyme responsible for catalyzing the formation of 
glutathione), glutathione peroxidase (GPX-1), drug 
metabolizing enzymes (cytochrome P-450s), and several ATP 
Binding Cassette (ABC) transporters that are responsible for 




Figure 1:  
This illustration indicates the involvement of PGC-1 coactivators, 
NRF-1/2 and TFAM in the regulation of mitochondrial biogenesis 
(Adapted from Dillion et al., 2012).  
 
 
NRF-1 and Oxidative stress 
Oxidative stress, an imbalance between the production of 
reactive oxygen species (ROS) and body antioxidant defences 
plays an important part in the pathogenesis of a variety of 
diseases. ROS can cause a serious damage to the cell through 
oxidation of proteins, DNA (including mitochondrial DNA), 
and nitrosylation of proteins (through generation of ROS), 
resulting to protein malfunction (Bugger and Abel, 2008). 
Cellular oxidative stress entails both cytosolic and 
mitochondrial oxidative stress and in addition, cytosolic 
oxidative stress contributes to mitochondrial dysfunction, 
mitochondrial oxidative stress and vice versa (Aroor et al., 
2012). Oxidative stress related diseases include type 2 
diabetes (Chang and Chuang, 2010; Niemann et al., 2017), 
cancer (Reuter et al., 2010; Sung et al., 2018), cardiovascular 
diseases (Dhalla et al., 2000; Higashi et al., 2009) and 
neurodegenerative diseases (Barnham et al., 2004; Kim et al., 
2015).  
 
Oxidative stress activates transcription of a variety of 
antioxidant genes through cis-acting sequence known as 
antioxidant response element (ARE) (Biswas and Chan, 2010). 
Some antioxidant and detoxification enzymes are 
transcriptionally induced during oxidative or electrophilic 
stress through ARE (Nguyen et al., 2003; Jyrkkänen et al., 
2011). Transcription factors can either transactivate or repress 
gene expression through binding to the ARE (Jyrkkänen et al., 
2011). NRF-1 binds to the antioxidant response elements 
(AREs) and regulates genes involved in protecting cells from 
oxidative damage.  In a study conducted by Parola and Novo 
(2005), hepatocytes lacking NRF-1 confirmed oxidative stress 
and there was a decreased expression of various ARE-
containing genes and up-regulation of CYP4A genes. It was 
further stated that NRF-1 had protective effects against 
oxidative stress and a potential role in lipid homeostasis in the 
liver. Chen et al. (2003) showed that defective GSH expression 
correlated with loss of NRF-1, suggesting its role in protecting 
fetal liver cells from oxidative stress. Loss of NRF-1 resulted 
to marked oxidative stress in cells, an indication of increased 
intracellular reactive oxygen species levels and cell death 
(Leung et al., 2003). In another study, Hernandez-Montes et al. 
(2006) suggested that the protective effects of genistein, a 
flavonoid depend largely on the activation of glutathione 




Figure 2:  
Pathway showing primary cellular defences of NRF-1 against of 
oxidative damage 
 
NRF-1 and Metabolic Syndrome 
Metabolic syndrome is characterized by a coming together of 
risk factors for cardiovascular diseases and diabetes usually 
linked to insulin resistance and obesity (Duncan and Schimidt, 
2001; Gepstein and Weiss, 2019). Cardiovascular disease is a 
class of diseases affecting the heart and/or blood vessels and 
its risk factors include smoking, elevated blood cholesterol 
levels, high blood pressure, physical inactivity, obesity, 
insulin resistance and type 2-diabetes (Oguntibeju et al., 
2009). Obesity, an energy imbalance due to excessive food 
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ingestion and insufficient physical activity is a chronic disease 
that serves as a triggering agent for the development of the 
metabolic syndrome (Gutiérrez-Salmeán et al., 2012). The 
occurrence of type 2 diabetes and its related metabolic 
disorders including obesity and insulin resistance is rapidly 
increasing throughout the world (Lai et al., 2009).  
 Type 2 diabetes mellitus is characterized by insulin 
resistance and dysfunction in pancreatic beta-cell (Patti et al., 
2003). Insulin resistance is generally referred as decline in the 
ability of insulin to stimulate the uptake of glucose from body 
peripheral tissues (Martins et al., 2012). ROS may likely play 
an essential role in the impairment of mitochondrial energy 
metabolism by participating in mitochondrial uncoupling (in 
type 2 diabetes and cardiac efficiency) thus directly damaging 
mitochondrial proteins (Bugger and Abel, 2008). Wang et al. 
(2004) reported that mitochondrial dysfunction takes part in 
the pathophysiology of insulin insensitivity and the activation 
of mitochondrial biogenesis could be a helpful in the 
prevention or treatment of insulin resistance and type 2 
diabetes. Many of the genes dysregulated in both diabetes and 
'prediabetes' are regulated by NRF-1 and PGC-1 (Patti, 2004; 
Sergi et al., 2019). The mechanism of insulin resistance by 
decreased mitochondrial function could be due to decreased 
PGC1, a coactivator of NRF-1 and subsequently, transcription 
and translation of Mitochondria (Lee et al., 2005). Cho et al. 
(2005) found out that the haplotypes of the NRF1 gene, the 
regulator of oxidative phosphorylation in mitochondria are 
associated with type 2 diabetes in the Korean population. In 
DM, expression of oxidative phosphorylation genes is 
decreased, perhaps as a result of decreased expression or 
transcriptional activity of NRF-1 (Patti et al., 2003).  
 The reduced expression of NRF-dependent genes could be 
due decrease in PGC-1 expression which leads to metabolic 
disturbances characteristic of insulin resistance and DM 
(Uguccioni et al., 2010). Choi et al. (2004) showed that in vitro 
exposure of L6 rat skeletal muscle cells to high glucose induced 
Tfam promoter expression and was mediated by NRF-1. They 
further stated that since, Tfam plays an essential role in the 
replication and transcription of mitochondrial DNA, the effect 
of glucose may explain the correlation between diabetes and 
dysfunctions of mitochondrial biogenesis and/or oxidative 
phosphorylation. The expression of GLUT4, a rate-limiting for 
glucose transport into muscle was indirectly regulated by NRF-
1 because NRF-1 is not a transcriptional activator of the 
GLUT4 gene (Baar et al., 2003). They found out that 
overexpression of NRF-1 resulted in increased expression of 
GLUT4 muscle and further stated that this could help to give 
an explanation on a mechanism that accounts for associated 
increase in the capacities for glucose transport and oxidative 
generation of ATP in skeletal muscle adapting to endurance 
exercise. Mitochondrial DNA copy number and mitochondrial 
gene expression are reduced in heart failure (Sano and Fukuda, 
2008). From available literature, not much information has 
been documented on the influence of NRF-1 in cardiovascular 
diseases. However, a study conducted by Garnier et al. (2003) 
showed that the expression of PGC-1α, NRF-1, and Tfam in a 





Figure 3:  
Involvement of PGC-1 and NRF-dependent transcription to expression and metabolic phenotype of insulin resistance and type 2 diabetes as 
proposed by Patti et al. (2003).  
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NRF-1 and Carcinogenesis 
Excessive production of ROS damage lipids, DNA, and 
proteins in the cell, disrupting cell function and it is 
detrimental to both normal and cancer cells (Schultz et al., 
2010; Pizzino et al., 2017). Cancer is a disease characterized 
and caused by dynamic genomic changes (Pikor et al., 2013). 
Genomic instability comes as a result of mutations in DNA 
repair genes and steer the development of cancer (Negrini et 
al., 2010).  It is a transient or persistent state that increases the 
spontaneous mutation rate, leading to gross genetic alterations 
such as rearrangements and changes in chromosome number 
(Pikor et al., 2013).  NRF-1 is essential to the cellular response 
to oxidative stress (Schultz et al., 2010). A potential molecular 
link between NRF-1 and cancer has been reported. NRF-1 is 
the main transcription factor regulating the expression of 
TOMM34 (Blesa et al., 2008).  
 TOMM34 is frequently upregulated in colorectal tumours 
and can be a potential target for novel anticancer drugs (Blesa 
et al., 2008). Xu et al. (2005) showed that hepatocyte-specific 
deletion of NRF-1 in mice led to apoptosis, inflammation and 
liver tumor development. It was further reported that the 
fuction of NRF-1 as a tumor suppressor in hepatocytes cannot 
be ruled out. Oh et al. (2012) showed that genomic instability 
can be caused due to loss of NRF-1 function and suggested 
that the influence of NRF-1 in cellular homeostasis goes 
beyond oxidative and proteolytic stress response to include 
genomic integrity maintenance. Since genomic instability is 
often linked with cancer and can be suggestive of a poor 
diagnosis for some types of cancer, it is imperative to conclude 
that NRF-1 plays an important in the prevention of cancer. The 
X gene, a viral oncogenic factor of hepatitis B virus (HBV) is 
one of the majors in HBV-induced hepatocarcinogenesis 
(Tokusumi et al. 2004). NRF-1 has been reported to be 
involved in the regulation of the expression of the HBV X 
gene (Tokusumi et al. 2004; Jin et al., 2017). 
 Zhao et al. (2011) showed that the knockdown of NRF-1 
increased inorganic arsenite (iAs3+) induced cytotoxicity and 
apoptosis in human keratinocytes. They reported that long 
isoforms of NRF-1 contributed to arsenic-induced antioxidant 
response in human keratinocytes and protected the cells from 
acute arsenic cytotoxicity. Similarly, a somatic inactivation of 
NRF-1 in the liver of mice resulted in hepatic cancer (Parola 
and Novo, 2005). Degradation of proteins by the proteasome 
plays a vital role in all major cellular pathways while an 
abnormal proteasome activity is linked with cancer (Xu et al., 
2012). According to a study by Radhakrishnan et al. (2010), 
the antioxidant response elements in NRF-1-mediated the 
upregulation of proteasome subunit genes. It was further 
stated that NRF-1-mediated proteasome homeostasis could be 
an attractive target for therapeutic intervention in cancer.  
 
NRF-1 and Neurodegenerative Diseases 
Neurodegenerative diseases which include Alzheimer's 
disease, Parkinson's disease and amyotrophic lateral sclerosis 
are caused by gradual loss of neurons (Lee et al., 2009). 
Alzheimer's disease is a progressive neurological disorder that 
causes death of brain cells and leads to disorientation, with 
impaired memory, thinking, and judgment. Parkinson disease 
(PD) is linked with progressive loss of dopaminergic neurons 
in the substantia nigra and widespread neuronal changes that 
cause complex and variable motor and nonmotor symptoms 
(Henchcliffe and Beal, 2008). Oxidative stress has been 
implicated in the pathophysiology of many neurological, 
especially neurodegenerative diseases (Gilgun-Sherki et al., 
2001; Kim et al., 2015). The brain is exposed throughout life 
to excitatory amino acids, whose metabolism is a factory of 
ROS, a source of oxidative stress (Gilgun-Sherki et al., 2001; 
Uttara et al., 2009).  
 Malfunctioning in physiology of mitochondrial plays a 
crucial role in the pathogenesis of the neurodegenerative 
disease (Satoh et al., 2013). Mitochondrial dysfunction is a 
prominent feature of Alzheimer's and Parkinson`s disease s 
which may be of vital importance in the genesis and increase 
of reactive oxygen species and the pathophysiology of the 
diseases (Yah et al., 2013). Piao et al. (2010) showed that 
mitochondrial activation by TFAM, NRF-1, and myr-AKT 
abrogated 1-methyl-4-phenyl-2, 3-dihydropyridinium ion 
(MPP+) -mediated the impairment on mitochondria and 
insulin signalling, resulting in the recovery of nigrostriatal 
neurodegeneration and hence, could be the critical points of 
therapeutic intervention for Parkinson’s diseases. Huntington 
disease (HD), another neurodegenerative disease is inherited 
and caused by an abnormal expansion of a CAG repeat in the 
huntingtin HTT (HD) gene and impaired mitochondrial 
biogenesis in response to energetic stress plays a significant 
role in its pathogenesis (Taherzadeh-Fard et al., 2011). They 
further stated that upregulation of transcriptional activators of 
PGC-1alpha which enhances the expression and activity of 
NRF-1 may be useful targets in the treatment of HD 
(Taherzadeh-Fard et al., 2011).  
 NRF-1 is a key transcription factor in the human genome 
and it is involved in neurite outgrowth in neuroblastoma cells 
(Wang et al., 2013; Jin et al., 2017). a-Pal/ NRF-1 is a critical 
transcriptional regulator of the human IAP (or CD47) gene, a 
memory-related gene that is up-regulated in hippocampus 
during the process of memory formation (Chang and Huang, 
2004; Huang et al., 1998). Due to the activation caused by a-
Pal/ NRF-1, an increase in IAP mRNA (neurtite outgrowth) 
was observed and this explains its role in memory formation 
(Chang et al., 2005). Lee et al., (2011) showed a new function 
of NRF-1 in maintaining proteasome homeostasis and 
protection against neuronal apoptosis.  Proteasome is a large 
intracellular protease found in all cells of the central nervous 
system (CNS) and it is accountable for the majority of 
intracellular protein degradation (Keller et al., 2002). Lee et 
al., (2011) revealed NRF-1 as a key transcriptional regulator 
required for the expression of proteasomal genes in neurons 
and suggested that the knockout of NRF-1 in the brain of mice 
may offer a model to study mechanisms of neurodegenerative 
diseases. The impairment of mitochondrial function plays a 
critical role in the pathogenesis of HD and that upstream 
transcriptional activators of PGC-1alpha may be useful targets 
in the treatment of HD (Lee et al., 2011). 
 
Activation of NRF-1 by plant metabolites 
Hernandez-Montes et al. (2006) suggested that the protective 
effects of genistein, a flavonoid depend largely on the 
activation of glutathione peroxidase, an antioxidant enzyme 
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which is mediated by NRF-1 activation. In another study, 
icariin, an active ingredient of plant herb Epimedium, 
increased the expression of PGC-1α, PPARα, and NRF-1 
during cardiomyocyte differentiation of murine ES cells in 
vitro in a dose-dependent manner (Ding et al., 2007). 
Epigallocatechin-3-gallate (EGCG) increased mRNA levels 
of nuclear respiratory factor NRF-1, medium chain acyl coA 
decarboxylase (MCAD), uncoupling protein+(UCP)3, and  
PPARα by 1.4 – 1.9-fold  in the skeletal muscle of high fat-
fed mice when compared to high fat-fed controls (Sae-tan et 
al., 2011). The expression of these genes which are all related 
to mitochondrial fatty acid oxidation suggest that EGCG could 
be helpful in alleviating obesity and type 2 diabetes. Kuo et al. 
(2012) showed that curcumin protected hepatocytes from high 
free fatty acid -induced lipoapoptosis and mitochondrial 
dysfunction due to mechanism of action related to 
improvements in mitochondrial function and biogenesis. 
NAFLD is associated with the metabolic syndrome, especially 
obesity, hyperlipidaemia and diabetes (Hiramitsu et al., 2014). 
Insulin resistance occurs in almost all patients with non-
alcoholic fatty liver disease (NAFLD, characterized by high 
serum concentration of free fatty acids, liver steatosis and 
hepatocyte apoptosis) and mitochondrial dysfunction likely 
plays a pivotal role in the progression of fatty liver into non-
alcoholic steatohepatitis (NASH) (Kuo et al., 2012). In the 
study, curcumin increased the levels of transcriptional factors 
that regulate mitochondrial biogenesis such as PGC1α, NRF1 
and Tfam.  
 The effect of combined bioactive dietary constituents 
(resveratrol and equol) on mitochondrial function was 
conducted (Davinelli et al., 2013). It was shown that the co-
administration of both compounds on HUVEC cells induced 
mitochondrial biogenesis factors such as PGC1-α, TFAM and 
NRF-1. They suggested that the co-administration of these 
agents may be a possible nutraceutical and/or anti-ageing 
strategy. Quercetin treatment has been found to induce 
expression of mitochondrial biogenesis activators (PGC-1𝛼, 
NRF-1, TFAM) in HepG2 cells (Rayamajhi et al., 2013). It 
was demonstrated that quercetin enhances cell survival against 
oxidative stress through heme oxygenase (HO-1)/carbon 
monoxide (CO) (an inducible cytoprotective mechanism in 
mammalian cell) dependent increase in mitochondrial 
biogenesis. Another study conducted by Hiramitsu et al. 
(2014) using a zebrafish model of diet-induced obesity, 
eriocitrin, a powerful antioxidative flavonoid in lemon 
ameliorated hepatic steatosis with activation of mitochondrial 
biogenesis by increasing NRF-1 and TFAM. The liver-
specific inactivation of NRF-1 leads to hepatic steatosis and 
neoplasia and this indicates that the therapeutic action of 
eriocitrin is through NRF1 induction. People with DS are 
known to show early aging associated with a decline in 
intellectual abilities, with a high tendency to develop 
neuropathological features associated with Alzheimer's 
disease (Valenti et al., 2013). Epigallocatechin-3-gallate has 
also been shown to promote mitochondrial biogenesis in 
human cells from subjects with Down's syndrome (DS) by 
increasing NRF-1 and T-FAM protein levels (Valenti et al., 
2013). It was reported from the study that EGCG treatment 
promises to be a therapeutic approach to counteract 
mitochondrial energy shortage in DS. 
 
Song et al. (2015) reported that the roots of Atractylodes 
macrocephala Koidzumi (Atractylodis Rhizoma Alba, ARA) 
enhanced glucose and lipid metabolism in C2C12 myotubes 
via mitochondrial regulation. The root extract was found to 
stimulate mitochondria biogenesis markers such as PGC1𝛼, 
NRF1, and TFAM with increase of ATP content. It was 
suggested that ARA extract and its active constituents possess 
therapeutic potential for the treatment of insulin resistance, 
obesity, and T2 diabetes. Boesenbergia pandurata has been 
found to stimulate exercise endurance through elevation of 
mRNA expression of key factors of mitochondria biogenesis 
and function such as NRF-1 (Kim et al., 2016). It was 
concluded that Boesenbergia pandurata could be a potential 
nutraceutical candidate for the enhancement of exercise 
endurance due on its mitochondrial biogenesis and exercise-
mimicking effects. The extract of orange-fleshed sweet potato 
has been shown to improve the expression of nrf-1 gene in 
palmitate-induced insulin resistant C2C12 cells (Ayeleso et 
al., 2018). In another study, it was shown that the neonatal 
administration of oleanolic acid, a a pentacyclic triterpenoid 
in plant could help to increase the expression of glut-4, cpt-1 
and nrf-1 in fructose-induced metabolic dysfunction in both 
young and adult rats (Molepo et al., 2018). 
 
Conclusion 
Nuclear respiratory factor-1 helps in the stimulation of the 
transcription of nuclear-encoded genes involved in regulating 
mitochondrial genome transcription and biogenesis. Oxidative 
stress which is thought to be involved in the development of 
many diseases activates transcription of a variety of 
antioxidant genes through cis-acting sequence known as 
antioxidant response element. NRF-1 has been implicated to 
play a role in mediating activation of oxidative stress response 
genes through antioxidant response element and hence, 
confirms its potential roles in chronic diseases. It can therefore 
be concluded that a mechanism by which medicinal plants and 
their bioactive compounds exert their pharmacological 
potentials could be through NRF- 1 as the therapeutic target in 
managing several chronic diseases. 
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